Direkt zum Inhalt
  • Paul Scherrer Institut PSI
  • PSI Research, Labs & User Services

Digital User Office

  • Digital User Office
  • DE
  • EN
  • FR
Paul Scherrer Institut (PSI)
Suche
Paul Scherrer Institut (PSI)

Hauptnavigation

  • Research at PSIÖffnen dieses Hauptmenu Punktes
    • Research Initiatives
    • Ethics and Research integrity
    • Scientific Highlights
    • Scientific Events
    • Scientific Career
    • PSI-FELLOW
    • PSI Data Policy
  • Research Divisions and LabsÖffnen dieses Hauptmenu Punktes
    • Overview
    • Research with Neutrons and Muons
    • Photon Science
    • Energy and Environment
    • Nuclear Energy and Safety
    • Biology and Chemistry
    • Scientific Computing, Theory and Data
    • Large Research Facilities
    • Logistics
  • Facilities and InstrumentsÖffnen dieses Hauptmenu Punktes
    • Overview
    • Large Research Facilities
    • Facilities
    • PSI Facility Newsletter
  • PSI User ServicesÖffnen dieses Hauptmenu Punktes
    • User Office
    • Methods at the PSI User Facilities
    • Proposals for beam time
    • Proposal Deadlines
    • Data Analysis Service (PSD)
    • EU support programmes
  • New ProjectsÖffnen dieses Hauptmenu Punktes
    • SLS 2.0
    • IMPACT
  • DE
  • EN
  • FR

Digital User Office (mobile)

  • Digital User Office

Sie befinden sich hier:

  1. PSI Home
  2. Labs & User Services
  3. PSD
  4. LXN
  5. Research Groups
  6. Therapeutic drug monitoring in sub-nanoliter volumes

Sekundäre Navigation

Laboratory for X-ray Nanoscience and Technologies (LXN)

  • About LXN
    • Organisational Structure
  • Open Positions
  • People
  • Research Groups Ausgeklappter Submenü Punkt
    • X-ray Nano-Optics
      • X-ray Optics for Imaging and Spectroscopy
        • Fresnel Zone Plate for X-ray Microscopy
        • Blazed X-ray Optics
        • Zernike X-ray Phase Contrast Microscopy
        • Fresnel Zone Plates for RIXS
        • Refractive Lenses by 2 Photon 3D Lithography
      • Wavefront Metrology and Manipulation
        • Vortex Fresnel Zone Plates
        • Grating-based Wavefront Metrology
      • X-ray Optics for XFELs
        • Diamond Fresnel Zone Plates
        • Beam Splitter Gratings for Spectral Monitoring
        • A Delay Line for Ultrafast Pump-Probe Experiments
        • X-ray Streaking for Ultrafast Processes
    • Molecular Nanoscience
      • On-surface Chemistry
      • Scanning Probe Transport
      • Spins in Molecular Monolayers
      • SiC: Surfaces and Interfaces
      • Our Research Team
    • Advanced Lithography and Metrology
      • EUV Interference Lithography
      • EUV Lensless Imaging
      • ALM Nanoscience
    • Quantum Photon Science
      • News and highlights
      • People
      • Open positions
      • Research themes
        • Imaging quantum many-body states
        • Nonlinear magnonics
        • Optical devices & methods
        • Rare-earth quantum magnets
        • Rydberg states in Si ∂-layers
        • Strained Ge laser (former research activity of H. Sigg & collaborators)
        • Van der Waals materials & devices
      • Infrastructure
        • Cristallina-Q
        • QPS optics lab
        • Nano-fabrication
      • Publications
      • QTC@PSI
    • Detectors
      • Projects
        • MYTHEN
        • GOTTHARD
        • EIGER
        • JUNGFRAU
        • MOENCH
        • AGIPD
        • Documentation
        • Software Releases
      • Research
      • Detectors Scientific Highlights
      • Publications
      • Team
  • Facilities and Equipment
    • Surface Science Lab
    • Scanning Electron Microscopy
    • Scanning Probe Microscopy
    • PEARL Beamline
    • XIL Facility at the SLS
    • Cleanroom Labs
  • Scientific Highlights and News
    • Archive
  • Publications
    • Archive

Info message

Dieser Inhalt ist nicht auf Deutsch verfügbar.
6. Juli 2016

Therapeutic drug monitoring in sub-nanoliter volumes

Hollow microneedles as produced at UBC in comparison with the tip of a conventional hypodermic needle.
Hollow microneedles as produced at UBC in comparison with the tip of a conventional hypodermic needle.
The chemical reaction scheme for the detection of vancomycin in low volume samples inside
microneedle lumens. Vancomycin-HRP is pre-loaded to the microneedle surface (1). Vancomycin present in the sample competes for the acetyl-L-lysine-D-alanine-D-alanin
The chemical reaction scheme for the detection of vancomycin in low volume samples inside
microneedle lumens. Vancomycin-HRP is pre-loaded to the microneedle surface (1). Vancomycin present in the sample competes for the acetyl-L-lysine-D-alanine-D-alanine binding sites on the microneedle surface and displaces vancomycin-HRP (2). The enzyme-linked TMB assay is used to quantify (in the optofluidic detection chamber/waveguide) the level of bound vancomycin-HRP remaining on the surface (3).
Integrated microneedle-optofluidic biosensor
Integrated microneedle-optofluidic biosensor

In an international collaboration between the University of the British Columbia (UBC) and the Paul Scherrer Institut (PSI), a promising system for painless and minimally-invasive therapeutic drug monitoring has been demonstrated. Results of the study have been published in the latest issue of the nature-journal “scientific reports”.

The proposed device is based on the combination of an optofluidic system with hollow microneedles – which were developed and fabricated at UBC – to extract extremely small volumes (< 1 nL) of interstitial fluid (ISF) to measure drug concentrations. The inner lumen of the microneedles was first functionalized for the detection of vancomycin using an enzyme-linked displacement assay. Quantification was achieved via absorbance measurements through optical fibres coupled to the optofluidic device.

The enzyme assay combined with the optofluidic sensing system for vancomycin detection provides high sensitivity clinically relevant ranges, a low limit of detection (< 100 nM) determined in extremely low sample volumes (0.6 nL), and rapid measurements (< 5 min in total) of drug binding to microneedles.

Using vancomycin as a target drug, the potential of the microneedle-optofluidic biosensor for therapeutic drug monitoring (TDM) was demonstrated for point of care applications using a minimally invasive sample extraction and limited needs for external equipment (only a diode laser and a photodetector were required). These results prove the potential of the proposed integrated sensors for the development of portable devices that can be used by patients to perform TDM with many drug candidates present in ISF.

Contact
Dr. Victor Cadarso
Lab. for Micro- and Nanoechnolgy
Paul Scherrer Institut
Telephone: +41 56 310 5146
E-mail: victor.cadarso@psi.ch
Original Publication
Integrated hollow microneedle-optofluidic biosensor for therapeutic drug monitoring in sub-nanoliter volumes
Sahan A. Ranamukhaarachchi, Celestino Padeste, Matthias Dübner, Urs O. Häfeli, Boris Stoeber, Victor J. Cadarso
Scientific reports 2016, 6, 29075; DOI: 10.1038/srep29075
Media Releases
UBC Media Release | July 25, 2016
EurekAlert Public Release | July 25, 2016

Mit Sidebar

Dr. Celestino Padeste

Laboratory for Micro-
and Nanotechnology
Paul Scherrer Institut
5232 Villigen PSI
Switzerland

Phone: +41 56 310 2141
Fax: +41 56 310 2646
celestino.padeste@psi.ch

top

Fussbereich

Paul Scherrer Institut

Forschungsstrasse 111
5232 Villigen PSI
Schweiz

Telefon: +41 56 310 21 11
Telefax: +41 56 310 21 99

Der Weg zu uns
Kontakt

Besucherzentrum psi forum
Schülerlabor iLab
Zentrum für Protonentherapie
PSI Bildungszentrum
PSI Guest House (in english)
PSI Gastronomie
psi forum-Shop

 

Service & Support

  • Telefonbuch
  • User Office
  • Accelerator Status
  • Publikationen des PSI
  • Lieferanten
  • E-Rechnung
  • Computing
  • Sicherheit

Karriere

  • Arbeiten am PSI
  • Stellenangebote
  • Aus- und Weiterbildung
  • Career Center
  • Berufsbildung
  • PSI Bildungszentrum

Für die Medien

  • Das PSI in Kürze
  • Zahlen und Fakten
  • Mediacorner
  • Medienmitteilungen
  • Social Media

Folgen Sie uns: Twitter (deutsch) LinkedIn Youtube Facebook Instagram Issuu RSS

Footer legal

  • Impressum
  • Nutzungsbedingungen/Datenschutz
  • Editoren-Login